We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Blood Analyzer Simultaneously Provides CBC and CRP

By LabMedica International staff writers
Posted on 23 Jul 2012
A compact analyzer simultaneously provides a complete blood count (CBC) and C-reactive protein (CRP) from just 18 μL of blood in only 4 minutes. More...
After a highly successful release in Japan, the instrument is now available in Europe.

Horiba Medical (Kyoto, Japan), specialists in automated in vitro diagnostic systems for hematology and chemistry analysis, launched the Microsemi CRP hematology analyzer.

The Microsemi CRP provides information of great clinical value enabling quicker and more accurate medical decisions to ultimately reduce hospitalization times and patient costs. Its powerful CRP analysis allows the screening of patient samples to detect the presence of inflammation caused by bacterial infections, or other treatable inflammatory disease.

Measurement is possible immediately after blood sample collection, making this analyzer the ideal choice for emergency testing. The Microsemi CRP can also be used to assess infection and inflammatory conditions that require progressive observation. In addition, its microsampling capabilities are ideal for pediatric blood analysis, requiring only 10µL for CBC and 18 µL for CBC+CRP, and can be used with capillary, as well as venous blood samples.

Comprehensive and efficient on-board software, color touch screen, alongside fast and easy access to results, adds to the Microsemi CRP’s success. Design features have created an environmentally friendly model (using a noncyanide reagent for hemoglobin measurement) that is compact, lightweight, and quiet. The Microsemi CRP does not require specialized staff.

According to Cleve Wright, UK general manager, Horiba Medical, “With over 2000 instruments successfully being used in Japan to date, UK clinicians can now benefit from the Microsemi CRP’s accuracy, convenience, and ability to support early and rapid diagnosis of patients.”

Related Links:

Horiba Medical



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Luteinizing Hormone Test
Luteinizing Hormone (LH) Rapid Test
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Switching to an experimental drug after liquid biopsy detection of breast cancer recurrence can improve outcomes (Photo courtesy of Shutterstock)

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Standard treatment for patients with advanced estrogen receptor (ER)-positive, HER2-negative breast cancer, a subtype driven by estrogen receptors that fuel tumor growth, often involves aromatase inhibitors,... Read more

Pathology

view channel
Image: A new at-home self-collection device aims to reduce the screening gap for cervical cancer (Photo courtesy of CU School of Medicine)

New At-Home Cervical Cancer Screening Device to Increase Accessibility for Patients

Cervical cancer is typically linked to certain types of human papillomavirus (HPV), which is passed through sexual contact. While many people are infected with HPV, only a small percentage will develop... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.